loader

commercial-stage biopharmaceutical

LATEST ARTICLES

BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Previously Treated Hepatocellular Carcinoma

pharmaceutical investing

Strongbridge Biopharma Reports Full-Year 2017 Financial Results

pharmaceutical investing

Sarepta Therapeutics Announces Fourth Quarter 2017 and Full-Year 2017 Financial Results

pharmaceutical investing

Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes

pharmaceutical investing

BeiGene Reports Fourth Quarter and Full Year 2017 Financial Results

pharmaceutical investing

BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China

BeiGene Announces Commercial Availability of VIDAZA in China

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule

pharmaceutical investing

BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Esophageal Squamous Cell Carcinoma

BeiGene Announces Closing of $800 Million Public Offering

pharmaceutical investing

BeiGene Announces Pricing of $750 Million Public Offering

Strongbridge Biopharma Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES